Modeling time | Groups | Dose/(crude drug g/kg) | n | Heart index/(g/g %) | Left ventricular index/(g/g %) | n | Myocardial infarct size/% |
1 week | Normal control group | - | 10 | 0.361 ± 0.034 | 0.256 ± 0.037 | 5 | 0 |
| Sham operation group | - | 10 | 0.357 ± 0.037 | 0.252 ± 0.027 | 5 | 0 |
| Model group | 10.4 | 11 | 0.437 ± 0.042*** | 0.299 ± 0.033*** | 6 | 30.8 ± 8.6 |
2 weeks | Normal control group | - | 10 | 0.365 ± 0.036 | 0.235 ± 0.030 | 5 | 0 |
| Sham operation group | - | 10 | 0.358 ± 0.017 | 0.230 ± 0.029 | 5 | 0 |
| Model group | 10.4 | 11 | 0.413 ± 0.034*** | 0.290 ± 0.017*** | 6 | 36.5 ± 13.0 |
4 weeks | Normal control group | - | 10 | 0.331 ± 0.019 | 0.252 ± 0.017 | 5 | 0 |
| Sham operation group | - | 10 | 0.331 ± 0.037 | 0.253 ± 0.029 | 5 | 0 |
| Model group | 10.4 | 11 | 0.426 ± 0.053*** | 0.317 ± 0.030*** | 6 | 36.4 ± 8.7 |